In the fourth webinar in the Hot Topics in Lung Cancer series, learn more about the latest advances in targeted therapies for advanced and metastatic NSCLC. Join expert faculty as they review current and emerging treatments for key oncogenic drivers, including KRAS, MET, RET, ALK, and HER2. A compelling patient vignette will demonstrate the real-world application of personalized treatment strategies, while a Clinician Spotlight from a recent quality improvement (QI) initiative will share practical approaches to improve the integration of targeted therapies. Join us to explore innovative solutions to common practice gaps and elevate care for patients and advancing care for patients with lung cancer.
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/virtual/innovations-targeted-therapies-redefining-care-advanced-metastatic-lung-cancer
- Start Date: 2025-05-14 05:00:00
- End Date: 2025-05-14 05:00:00
- Credit Details: IPCE Credits: 1.5 hours
AAPA Category 1 Credit™️: 1.5 hours
AMA PRA Category 1 Credit™️: 1.5 hours
Nursing: 1.5 hours
Pharmacy: 1.5 hours - Commercial Support: Source: astrazeneca-pharmaceuticals - Amount: 0.0 - Is Kind Support: False Source: daiichi-sankyo,-inc - Amount: 0.0 - Is Kind Support: False Source: lilly-usa-llc - Amount: 0.0 - Is Kind Support: False
- Activity Type: Live Course
- CME Finder Type: Conference
- Fee to Participate: No, it's free
- Measured Outcome: Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest